Is cancer a metabolic disease?

Area of Science:

• Oncology
• Metabolic Biology
• Biochemistry

Background:

• Cancer is increasingly recognized as a metabolic disease, not just a proliferative disorder.
• Tumor growth necessitates significant rewiring of cellular metabolic pathways.
• Key metabolic alterations include increased glucose and glutamine uptake, enhanced glycolysis, and lactate secretion.

Purpose of the Study:

• To review recent research on cancer metabolism.
• To investigate the reasons behind cancer cells' metabolic reprogramming.
• To determine if metabolic changes are a cause or consequence of cancer proliferation.
• To assess the potential of targeting cancer metabolism for therapeutic benefit.

Main Methods:

• Review of current scientific literature on cancer metabolism.
• Analysis of oncogene and tumor suppressor roles in metabolic alterations.
• Examination of metabolic profiles in tumor cells.
• Exploration of the tumor microenvironment's metabolic aspects.

Main Results:

• Cancer cells exhibit distinct metabolic profiles, including high glucose consumption and lactate production.
• Oncogenes and tumor suppressors influence these metabolic changes.
• Metabolic reprogramming supports rapid cell growth and proliferation.
• Potential roles in reactive oxygen species protection and lactate's function in the tumor microenvironment are suggested.

Conclusions:

• Cancer's metabolic reprogramming is a critical aspect of tumor development.
• The relationship between proliferation and metabolic changes requires further elucidation.
• Targeting cancer metabolism holds promise as a novel therapeutic strategy.